Saturday, December 04, 2021

NEWS

WHO tests 3 more drugs in a broad search for Covid-19 treatments

WHO tests 3 more drugs in a broad search for Covid-19 treatments

Geneva, Aug 12 (Prensa Latina) The World Health Organization (WHO) announced Wednesday the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized patients to test three new drugs (artesunate, imatinib and infliximabtres) in Covid-19 patients.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

The Solidarity PLUS trial is a platform trial that represents the largest global collaboration among WHO Member States. It involves thousands of researchers in over 600 hospitals in 52 countries, 16 more countries than the first phase of trials.

These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalized COVID-19 patients.

They are already used for other indications: artesunate is used for severe malaria, imatinib for certain cancers, and infliximab for diseases of the immune system such as Crohn’s Disease and rheumatoid arthritis.

‘Finding more effective and accessible therapeutics for COVID-19 patients remains a critical need, and WHO is proud to lead this global effort,’ said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.

pgh/Pll/msm / cdg

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.